1. Home
  2. YMAB vs GRRR Comparison

YMAB vs GRRR Comparison

Compare YMAB & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • GRRR
  • Stock Information
  • Founded
  • YMAB 2015
  • GRRR 2001
  • Country
  • YMAB United States
  • GRRR United Kingdom
  • Employees
  • YMAB N/A
  • GRRR N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • GRRR Computer Software: Prepackaged Software
  • Sector
  • YMAB Health Care
  • GRRR Technology
  • Exchange
  • YMAB Nasdaq
  • GRRR Nasdaq
  • Market Cap
  • YMAB 386.7M
  • GRRR 391.9M
  • IPO Year
  • YMAB 2018
  • GRRR N/A
  • Fundamental
  • Price
  • YMAB $8.57
  • GRRR $17.29
  • Analyst Decision
  • YMAB Buy
  • GRRR Buy
  • Analyst Count
  • YMAB 10
  • GRRR 1
  • Target Price
  • YMAB $13.91
  • GRRR $18.00
  • AVG Volume (30 Days)
  • YMAB 2.2M
  • GRRR 1.4M
  • Earning Date
  • YMAB 08-08-2025
  • GRRR 08-14-2025
  • Dividend Yield
  • YMAB N/A
  • GRRR N/A
  • EPS Growth
  • YMAB N/A
  • GRRR N/A
  • EPS
  • YMAB N/A
  • GRRR N/A
  • Revenue
  • YMAB $85,385,000.00
  • GRRR $93,325,178.00
  • Revenue This Year
  • YMAB N/A
  • GRRR $38.13
  • Revenue Next Year
  • YMAB $13.97
  • GRRR $28.55
  • P/E Ratio
  • YMAB N/A
  • GRRR N/A
  • Revenue Growth
  • YMAB N/A
  • GRRR 18.22
  • 52 Week Low
  • YMAB $3.55
  • GRRR $3.01
  • 52 Week High
  • YMAB $16.11
  • GRRR $44.15
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.31
  • GRRR 49.73
  • Support Level
  • YMAB $8.50
  • GRRR $15.76
  • Resistance Level
  • YMAB $8.56
  • GRRR $18.75
  • Average True Range (ATR)
  • YMAB 0.02
  • GRRR 1.19
  • MACD
  • YMAB -0.12
  • GRRR 0.05
  • Stochastic Oscillator
  • YMAB 83.33
  • GRRR 48.21

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.

Share on Social Networks: